PMCB Other Disclosure
Abecassis Michael M · SEC Form 4 · Filed Jul 17, 2026
Other
Reported value range
Not reported
Abecassis Michael M Director
PMCB
PharmaCyte Biotech
PMCB
Transaction date
Mar 31, 2026
Public filing date
Jul 17, 2026
Filing lag
Filed 108 days later
PMCB daily price context
Close on/before transaction
$0.67
Mar 31, 2026
Close before public filing
$0.66
Jul 16, 2026
Return since public filing
-24.08%
Through Aug 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 0 shares
- SEC ownership
- Direct
- Transaction code
- J
- Form
- 4/A
- Filing identifier
- 0001683168-26-005621
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Pharma Cyte Biotech, Inc. PMCB Current | Other | Mar 31, 2026 | Not reported |